NCT01013129 2021-11-11
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
Portland VA Medical Center
Completed
Clinical Trials
10 trialsNCT01083368 2019-08-21
Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
Case Comprehensive Cancer Center
Phase 1/2 Completed
NCT00089609 2018-04-20
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00899184 2017-05-19
DNA Changes in Patients With Prostate Cancer
Eastern Cooperative Oncology Group
Completed
NCT00897351 2017-05-17
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Eastern Cooperative Oncology Group
Completed
NCT01120262 2016-10-07
S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin
SWOG Cancer Research Network
Completed
NCT00900185 2015-04-30
Study of a Polymorphism in Patients With Prostate Cancer
National Cancer Institute (NCI)
Completed
NCT01338792 2014-03-10
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
University of Southern California
Phase 2 Completed
NCT00601406 2013-08-26
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00758173 2013-08-26
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Unknown